Wird geladen...
Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection
Immune-checkpoint inhibitors (ICPIs), including antibodies against cytotoxic T-lymphocyte associated antigen 4 and programmed cell death protein 1, have been shown to induce durable complete responses in a proportion of patients in the first-line and refractory setting in advanced melanoma and renal...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2018-06-01
|
| Schriftenreihe: | Therapeutic Advances in Medical Oncology |
| Online Zugang: | https://doi.org/10.1177/1758835918777427 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|